Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Consistency Between Treatment Responses in Patient-Derived Organoid (PDO) Models and Clinical Outcomes of Neoadjuvant Therapy, Conversion Therapy and Palliative Therapy in Gastric Cancer

NCT05203549 is registered in ClinicalTrials.gov with D1 Medical Technology (Shanghai) Co., Ltd, China as lead sponsor.

NCT NCT05203549
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05203549 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Consistency Between Treatment Responses in Patient-Derived Organoid (PDO) Models and Clinical Outcomes of Neoadjuvant Therapy, Conversion Therapy and Palliative Therapy in Gastric Cancer
Lead sponsor
D1 Medical Technology (Shanghai) Co., Ltd, China
Phase
Observational
Overall status
Unknown status
Start date
May 1, 2021
Completion date
June 30, 2023
Enrollment
250 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastric cancer